Board Meeting - Board Meeting On 28Th May 2018.
The meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 28th May 2018 to consider the Unaudited Financial Results for the quarter & year ended 31st March 2018. Board Meeting - Board Meeting On 28Th May 2018.
The meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 28th May 2018 to consider the Unaudited Financial Results for the quarter & year ended 31st March 2018. Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2018.
Certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2018. Compliance Certificate For The March 31, 2018.
Compliance Certificate certifying maintenance of physical and electronic transfer facility under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2018. Shareholding for the Period Ended March 31, 2018
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nirmala LDesignation :- Company Secretary and Compliance Officer Bank fraud: Enforcement Directorate attaches assets worth Rs 56 crore of Kolkata firm
Bank fraud: Enforcement Directorate attaches assets worth Rs 56 crore of Kolkata firmThe case pertains to R P Iinfo Systems and its directors, Shivaji Panja, Kaustuv Ray and Vinay Bafna, accused of cheating a consortium of banks of Rs 515 crore. Financial Results For The Period Ended 31.12.2017
The unaudited financial results for the quarter and period ended 31st December 2017 has been adopted and approved by the Audit Committee and Board of Directors in the meeting held today Board Meeting-Outcome of Board Meeting
1. Considered and approved Unaudited Financial Statements for the quarter and Nine months period ended 31st December, 2017. 2. Allotment of Equity Shares on preferential basis to the share warrant holders, as the entire warrant money has been received Board Meeting On 12Th Feb 2018.
The meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 12th February 2018 to consider among others, the Unaudited Financial Results for the quarter ended 31st December 2017.